Abstract

Patients in Scotland with multiple sclerosis (MS) will now be able to access Sativex on the NHS, according to the Scottish Medicines Consortium (SMC). The approval means the cannabis-based medicine is now available on the NHS for patients with MS across the UK. Sativex, manufactured by GW Pharma, is an oromucosal spray that contains both […]

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call